BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8782352)

  • 1. Preparation and characterization of a biodegradable microparticle antigen/cytokine delivery system.
    Rafferty DE; Elfaki MG; Montgomery PC
    Vaccine; 1996 Apr; 14(6):532-8. PubMed ID: 8782352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of secretory and serum antibody responses following oral administration of antigen with bioadhesive degradable starch microparticles.
    Montgomery PC; Rafferty DE
    Oral Microbiol Immunol; 1998 Jun; 13(3):139-49. PubMed ID: 10093528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of rat tear IgA antibody responses following intranasal immunization with antigen and CpG ODN.
    Gill RF; Montgomery PC
    Curr Eye Res; 2002 Mar; 24(3):228-33. PubMed ID: 12221533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inductive pathways leading to rat tear IgA antibody responses.
    Ridley Lathers DM; Gill RF; Montgomery PC
    Invest Ophthalmol Vis Sci; 1998 May; 39(6):1005-11. PubMed ID: 9579480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of immunization route on rat serum and tear antibody responses to Chlamydia trachomatis.
    Davidson HJ; Byrnes SA; Montgomery PC
    Reg Immunol; 1993; 5(2):114-9. PubMed ID: 8217553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo adjuvant effect of interleukins 5 and 6 on rat tear IgA antibody responses.
    Pockley AG; Montgomery PC
    Immunology; 1991 May; 73(1):19-23. PubMed ID: 2045126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of immunization route and sequence of stimulation on the induction of IgA antibodies in tears.
    Montgomery PC; Majumdar AS; Skandera CA; Rockey JH
    Curr Eye Res; 1984 Jun; 3(6):861-5. PubMed ID: 6734263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen.
    Challacombe SJ; Rahman D; Jeffery H; Davis SS; O'Hagan DT
    Immunology; 1992 May; 76(1):164-8. PubMed ID: 1628895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal delivery of macromolecules using solid-state biodegradable microstructures.
    Wendorf JR; Ghartey-Tagoe EB; Williams SC; Enioutina E; Singh P; Cleary GW
    Pharm Res; 2011 Jan; 28(1):22-30. PubMed ID: 20535531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody production in rats following ocular-topical or gastrointestinal immunization: kinetics of local and systemic antibody production.
    Peppard JV; Mann RV; Montgomery PC
    Curr Eye Res; 1988 May; 7(5):471-81. PubMed ID: 3261679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of ad libitum drinking water administration of bovine serum albumin in Leghorn chickens.
    Ameiss KA; Danforth HD; McElroy AP; Barri A; Berghman LR; Caldwell DJ
    Poult Sci; 2004 Sep; 83(9):1535-8. PubMed ID: 15384904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced mucosal and systemic immune responses obtained by porous silica nanoparticles used as an oral vaccine adjuvant: effect of silica architecture on immunological properties.
    Wang T; Jiang H; Zhao Q; Wang S; Zou M; Cheng G
    Int J Pharm; 2012 Oct; 436(1-2):351-8. PubMed ID: 22721849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel polymer-grafted starch microparticles for mucosal delivery of vaccines.
    Heritage PL; Loomes LM; Jianxiong J; Brook MA; Underdown BJ; McDermott MR
    Immunology; 1996 May; 88(1):162-8. PubMed ID: 8707344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery.
    Witschi C; Mrsny RJ
    Pharm Res; 1999 Mar; 16(3):382-90. PubMed ID: 10213368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of immunization route on mucosal and systemic immune response in Atlantic salmon (Salmo salar).
    Valdenegro-Vega VA; Crosbie P; Vincent B; Cain KD; Nowak BF
    Vet Immunol Immunopathol; 2013 Jan; 151(1-2):113-23. PubMed ID: 23206403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parameters influencing the expression of IgA antibodies in tears.
    Montgomery PC; Rockey JH; Majumdar AS; Lemaitre-Coelho IM; Vaerman JP; Ayyildiz A
    Invest Ophthalmol Vis Sci; 1984 Mar; 25(3):369-73. PubMed ID: 6607907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbon nanotube-protein carriers enhance size-dependent self-adjuvant antibody response to haptens.
    Parra J; Abad-Somovilla A; Mercader JV; Taton TA; Abad-Fuentes A
    J Control Release; 2013 Sep; 170(2):242-51. PubMed ID: 23735572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-specific IgA response of NALT and cervical lymph node cells in antigen-primed rats.
    Asakura K; Saito H; Hata M; Kataura A
    Acta Otolaryngol; 1998 Nov; 118(6):859-63. PubMed ID: 9870634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems.
    Delgado A; Lavelle EC; Hartshorne M; Davis SS
    Vaccine; 1999 Jul; 17(22):2927-38. PubMed ID: 10438065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjugation of protein antigen to microparticulate beta-glucan from Saccharomyces cerevisiae: a new adjuvant for intradermal and oral immunizations.
    Berner VK; Sura ME; Hunter KW
    Appl Microbiol Biotechnol; 2008 Oct; 80(6):1053-61. PubMed ID: 18677470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.